1.Sales and profit
See section β- Yuanbao Inc. had $608M of revenue in fiscal 2025, up 33.3% on the year before.
- Yuanbao Inc. made $182M of net profit in fiscal 2025.
Yuanbao Inc.
YB Nasdaq Insurance Agents, Brokers & Service Financials FY2023βFY2025
Yuanbao Inc. had $608M of revenue in fiscal 2025, up 33.3% on the year before.
KIRAβs summary AI analyst
Hi! I read Yuanbao Inc.βs latest annual report (fiscal 2025). Here is what stands out:
3 strengths
2.Cash and shareholders
See section β- Free cash flow was $205M in fiscal 2025, 33.8% of revenue.
- No open-market insider trades in the last 12 months.
3.Financial health
See section β- Yuanbao Inc. passes 5 of 8 financial health tests (Piotroski F-score).
Yuanbao Inc. in 30 seconds
Good So-so Weak
Good
Are sales growing?
+33.3%
Yes. Sales grew 33.3% last year.
Good
Does it make a profit?
29.9%
Yes. It keeps 29.9% of every sale as profit.
Good
Does profit turn into cash?
33.8%
Yes. 33.8% of sales ends up as free cash.
So-so
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Key numbers, fiscal 2025
Market cap
Last close times the latest diluted share count, so it is approximate.
β
P/E
Last close divided by diluted earnings per share over the last four quarters.
β
On $3.81 EPS (TTM)
Sales and profit
Is it selling more, and how much does it keep?
Revenue and margins
KIRA Β· Yuanbao Inc. had $608M of revenue in fiscal 2025, up 33.3% on the year before.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
FY23
Revenue $289M
FY24
Revenue $456M
FY25
Revenue $608M
Margins, % of revenue
FY23
Gross 93.3%
Operating β
Net 9.9%
FCF 21.4%
FY24
Gross 94.9%
Operating β
Net 26.4%
FCF 36.7%
FY25
Gross 96.2%
Operating β
Net 29.9%
FCF 33.8%
Gross
Operating
Net
FCF
Net income and earnings per share
KIRA Β· Yuanbao Inc. made $182M of net profit in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
FY23
Net income $28.7M
FY24
Net income $120M
FY25
Net income $182M
Diluted EPS
FY23
Diluted EPS β$3.99
FY24
Diluted EPS $2.66
FY25
Diluted EPS $3.81
Cash and shareholders
How much cash comes in, and where does it go?
Cash flow
KIRA Β· Free cash flow was $205M in fiscal 2025, 33.8% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
FY23
Free cash flow $61.7M
FY24
Free cash flow $167M
FY25
Free cash flow $205M
Cash from operations vs capital spending
FY23
Cash from operations $62.4M
Capital spending $0.7M
FY24
Cash from operations $168M
Capital spending $0.5M
FY25
Cash from operations $208M
Capital spending $2.6M
Cash from operations
Capital spending
Dividends, buybacks and share count
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
FY23
Dividends β
Buybacks β
FY24
Dividends β
Buybacks β
FY25
Dividends β
Buybacks β
Dividends
Buybacks
Diluted shares outstanding (annual)
FY23
Diluted shares 0.01B
FY24
Diluted shares 0.05B
FY25
Diluted shares 0.05B
Insider trades
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Financial health
Can it carry its debts, and how well does it use its money?
Balance sheet
Cash, debt and the ratios that show how comfortably Yuanbao Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
FY23
Cash $121M
Debt β
FY24
Cash $307M
Debt β
FY25
Cash $527M
Debt β
Cash
Debt
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $121M | $307M | $527M |
| Current ratio | β | 2.8x | 3.9x |
| Quick ratio | β | 2.8x | 3.9x |
| Total assets | β | $381M | $665M |
| Total liabilities | β | $136M | $187M |
| Shareholders' equity | β$301M | β$224M | $478M |
| Net debt (β = net cash) | β | β | β |
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
FY23
Return on capital β
Return on equity β
Return on assets β
FY24
Return on capital β
Return on equity β
Return on assets 31.6%
FY25
Return on capital β
Return on equity 143.2%
Return on assets 34.8%
Return on capital
Return on equity
Return on assets
Piotroski F-score
KIRA Β· Yuanbao Inc. passes 5 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 8 |
| Accruals ratio | β | β12.5% | β5.0% |
| Altman Z'' | β | β | β |
All figures
Every number, year by year.
3 years of figures
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $289M | $456M | $608M |
| Provision for credit losses | $0.1M | $0.5M | β$0.1M |
| Gross profit | $269M | $433M | $585M |
| Research and development | $18.1M | $32.1M | $50.8M |
| Pretax income | $29.0M | $124M | $196M |
| Income tax | $0.0M | $3.6M | $14.1M |
| Net income | $28.7M | $120M | $182M |
| Net income to common | β$47.0M | $60.6M | $279M |
| Diluted EPS | β$3.99 | $2.66 | $3.81 |
| Diluted shares | 0.01B | 0.05B | 0.05B |
| Cash flow | |||
| Cash from operations | $62.4M | $168M | $208M |
| Capital expenditure | $0.7M | $0.5M | $2.6M |
| Free cash flow | $61.7M | $167M | $205M |
| Stock-based compensation | $5.2M | $8.9M | $10.3M |
| Balance sheet | |||
| Cash and short-term investments | $121M | $307M | $527M |
| Current assets | β | $366M | $637M |
| Current liabilities | β | $129M | $163M |
| Property and equipment, net | β | $0.7M | $2.0M |
| Intangible assets | β | $8.0M | $9.2M |
| Total assets | β | $381M | $665M |
| Total liabilities | β | $136M | $187M |
| Shareholders' equity | β$301M | β$224M | $478M |
| Margins | |||
| Gross margin | 93.3% | 94.9% | 96.2% |
| Net margin | 9.9% | 26.4% | 29.9% |
| FCF margin | 21.4% | 36.7% | 33.8% |
| Returns | |||
| Return on equity | β | β | 143.2% |
| Return on assets | β | 31.6% | 34.8% |
| Return on tangible equity | β | β | 59.6% |
| Growth | |||
| Revenue growth | β | 58.1% | 33.3% |
| Net income growth | β | 319.5% | 51.2% |
| EPS growth | β | β | 43.4% |
| FCF growth | β | 171.0% | 22.7% |
| Share count change | β | 283.7% | 5.4% |
| Financial health | |||
| Current ratio | β | 2.8x | 3.9x |
| Quick ratio | β | 2.8x | 3.9x |
| Capital allocation | |||
| Capex / revenue | 0.2% | 0.1% | 0.4% |
| Stock comp / revenue | 1.8% | 1.9% | 1.7% |
| Quality scores | |||
| Piotroski F-score | β | β | 5.0 |
| Accruals ratio | β | β12.5% | β5.0% |
Source: SEC EDGAR XBRL filings (CIK 0001995520). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. Per-share figures are per US-listed share (1 ADS = 6 ordinary shares). For information only β not investment advice. Check the original filings before relying on any figure.